These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 20551301)

  • 21. Colesevelam: in pediatric patients with heterozygous familial hypercholesterolemia.
    Perry CM
    Paediatr Drugs; 2010 Apr; 12(2):133-40. PubMed ID: 20218749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose and low-density lipoprotein cholesterol lowering in elderly patients with type 2 diabetes: focus on combination therapy with colesevelam HCl.
    Marrs JC
    Drugs Aging; 2012 May; 29(5):e1-e12. PubMed ID: 22530704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
    Simons WR; Hagan MA
    Pharmacoeconomics; 2010; 28(9):765-80. PubMed ID: 20799756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of colesevelam HCl in the treatment of elderly patients.
    Gavin JR; Jones MR; Ford DM; Truitt KE
    Drugs Aging; 2014 Jun; 31(6):461-70. PubMed ID: 24777691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
    Feldman T; Davidson M; Shah A; Maccubbin D; Meehan A; Zakson M; Tribble D; Veltri E; Mitchel Y
    Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.
    Rosenstock J; Fonseca VA; Garvey WT; Goldberg RB; Handelsman Y; Abby SL; Lai YL; Jin X; Misir S; Nagendran S; Jones MR
    Endocr Pract; 2010; 16(4):629-40. PubMed ID: 20634175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colesevelam: a new and improved bile acid sequestrant?
    Tziomalos K; Karagiannis A; Mikhailidis DP; Athyros VG
    Curr Pharm Des; 2013; 19(17):3115-23. PubMed ID: 23317402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of colesevelam hydrochloride in the treatment of dyslipidemia: a review.
    Davidson MH
    Expert Opin Pharmacother; 2007 Oct; 8(15):2569-78. PubMed ID: 17931091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pravastatin: a new drug for the treatment of hypercholesterolemia.
    Jungnickel PW; Cantral KA; Maloley PA
    Clin Pharm; 1992 Aug; 11(8):677-89. PubMed ID: 1511541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expanded colesevelam administration options with oral suspension formulation for patients with diabetes and hypercholesterolemia.
    Dayer-Berenson L; Finckenor M
    Postgrad Med; 2014 May; 126(3):126-34. PubMed ID: 24918798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire.
    Wedlake L; Thomas K; Lalji A; Anagnostopoulos C; Andreyev HJ
    Clin Ther; 2009 Nov; 31(11):2549-58. PubMed ID: 20109999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colesevelam hydrochloride: a non-absorbed, polymeric cholesterol-lowering agent.
    Davidson MH; Dicklin MR; Maki KC; Kleinpell RM
    Expert Opin Investig Drugs; 2000 Nov; 9(11):2663-71. PubMed ID: 11060828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.
    Bays HE; Goldberg RB; Truitt KE; Jones MR
    Arch Intern Med; 2008 Oct; 168(18):1975-83. PubMed ID: 18852398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colesevelam (Welchol) for hypercholesterolemia.
    Med Lett Drugs Ther; 2000 Oct; 42(1091):102-4. PubMed ID: 11056044
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia.
    Knapp HH; Schrott H; Ma P; Knopp R; Chin B; Gaziano JM; Donovan JM; Burke SK; Davidson MH
    Am J Med; 2001 Apr; 110(5):352-60. PubMed ID: 11286949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of colesevelam hydrochloride for the treatment of type 2 diabetes.
    Younk LM; Davis SN
    Expert Opin Drug Metab Toxicol; 2012 Apr; 8(4):515-25. PubMed ID: 22432790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sitagliptin: a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
    Miller S; St Onge EL
    Ann Pharmacother; 2006; 40(7-8):1336-43. PubMed ID: 16868220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pitavastatin: a new HMG-CoA reductase inhibitor.
    Wensel TM; Waldrop BA; Wensel B
    Ann Pharmacother; 2010 Mar; 44(3):507-14. PubMed ID: 20179258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.
    Handelsman Y; Goldberg RB; Garvey WT; Fonseca VA; Rosenstock J; Jones MR; Lai YL; Jin X; Misir S; Nagendran S; Abby SL
    Endocr Pract; 2010; 16(4):617-28. PubMed ID: 20634176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.